Xilio Therapeutics, Inc. (NASDAQ: XLO) will implement a 1-for-14 reverse stock split of its common stock effective at 5:00 p.m ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE